Patents by Inventor Sylvain Lehmann

Sylvain Lehmann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PROCESS FOR PREPARING A PEPTIDE SAMPLE
    Publication number: 20220196524
    Abstract: A process for preparing a peptide sample from a biological sample, and a process for detecting or quantifying proteins including the process for preparing a sample. Also disclosed is the use of these processes for the detection or monitoring of a condition or a disease.
    Type: Application
    Filed: May 19, 2020
    Publication date: June 23, 2022
    Inventors: Sylvain LEHMANN, Christophe HIRTZ, Jérôme VIALARET
  • Method of In Vitro Diagnosis of a Neurological Disorder
    Publication number: 20160116488
    Abstract: The present invention relates to a new method for the in vitro diagnosis of a neurological disorder, more particularly of Alzheimer's disease (AD) and of mild cognitive impairment (MCI). The present invention also relates to the use of orexin-A (hypocretin-1), a specific fragment thereof, a nucleotide encoding the same or a combination thereof, as a biomarker for the in vitro diagnosis of a neurological disorder, more particularly of Alzheimer's disease (AD), alone or in combination with other known bio markers for the diagnosis of AD. The present invention finally relates to kits for the in vitro diagnosis of a neurological disorder, more particularly of AD, comprising means for the detection of orexin-A.
    Type: Application
    Filed: May 15, 2014
    Publication date: April 28, 2016
    Inventors: Sylvain Lehmann, Yves Dauvilliers, Audrey Gabelle
  • METHOD FOR PREDICTING THE RESPONSE TO A TREATMENT AGAINST HEPATITIS C
    Publication number: 20140051079
    Abstract: The invention relates to a method for predicting the response to an interferon-based treatment in a patient infected with hepatitis C virus. This method consists in determining the presence of apolipoprotein CIII and/or of a multimeric form of human serum albumin in a sample of biological fluid from the patient.
    Type: Application
    Filed: December 14, 2011
    Publication date: February 20, 2014
    Applicant: CENTRE HOSPITALIER UNIVERSITAIRE DE MONTPELLIER
    Inventors: Sylvain Lehmann, Stephane Roche, Jacques Ducos, Laurent Tiers
  • Products and method for the decontamination of prions
    Patent number: 7959858
    Abstract: The invention relates to the use of Cu and the derivatives thereof, for the decontamination of prions, especially for decontaminating medical devices or medical surgical devices at risk, for decontaminating work surfaces, and for decontaminating any potentially infectious compound.
    Type: Grant
    Filed: May 24, 2005
    Date of Patent: June 14, 2011
    Assignee: Centre National de la Recherche Scientifique (C.N.R.S.)
    Inventors: Sylvain Lehmann, Jérôme Solassol
  • Products and Method for the Decontamination of Prions
    Publication number: 20080075630
    Abstract: The invention relates to the use of Cu and the derivatives thereof, for the decontamination of prions, especially for decontaminating medical devices or medical surgical devices at risk, for decontaminating work surfaces, and for decontaminating any potentially infectious compound.
    Type: Application
    Filed: May 24, 2005
    Publication date: March 27, 2008
    Inventors: Sylvain Lehmann, Jerome Solassol